UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM

10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~June 30, ~~2020~~

2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File

No. 001-39501

Prime Impact Acquisition I

(Exact name of registrant as specified in its charter)


Cayman Islands	~~001-39501~~		98-1554335
(State or other jurisdiction of ~~incorporation or organization)~~ incorporation)	(~~Commission~~ ~~File Number)~~ IRS Employer Identification No.)
		~~(I.R.S. Employer~~ ~~Identification Number)~~

123 E San Carlos Street, Suite 12 San Jose, California			95112
(Address of principal executive offices)			(Zip Code)

(650)
825-6965

(Registrant’s telephone number, including area ~~code: (650)~~ ~~825-6965~~

code)

Not Applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one ~~share of Class A ordinary shares, and one Warrant to acquire~~ ~~one-third~~Class A ordinary share and one-third of a Warrant to acquire one Class A ordinary share	PIAI.U	The New York Stock Exchange
Class A ordinary ~~share,~~shares, par value $0.0001 per share	PIAI	The New York Stock Exchange
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50	PIAI.W	The New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation

S-T (§

(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a

non-accelerated

filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule

12b-2

of the Exchange Act.


Large accelerated filer	☐		Accelerated filer	☐

Non-accelerated filer	☒		Smaller reporting company	☒


		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule

12b-2

of the Exchange Act). Yes ☒ No ☐

As of ~~November~~August 11, ~~2020, 32,408,414~~2022, there were 3,055,170 units, each unit consisting of one Class A ordinary ~~shares,~~share, par value $0.0001 per share, and one third of a warrant to acquire one Class A ordinary share

, 29,353,244 Class A ordinary shares, 8,102,103 Class B ordinary shares, par value $0.0001 per share, and 15,505,506 warrants, were issued and ~~outstanding.~~

outstanding, respectively.

PART I - FINANCIAL INFORMATION

~~Item 1. Financial Statements.~~

Item 1.

Condensed Financial Statements.

PRIME IMPACT ACQUISITION I

~~UNAUDITED~~

CONDENSED BALANCE ~~SHEET~~

~~SEPTEMBER 30, 2020~~

Assets

Current assets:

Cash
   $ 2,563,468
Prepaid expenses
   410,350


Total current assets
   2,973,818
Investments held in Trust Account
   299,998,798


Total Assets
   $ 302,972,616


Liabilities and Shareholders’ Equity

Current liabilities:

Accounts payable
   $ 526,857
Accrued expenses
   77,300
Advance - related party
   900,000


Total current liabilities
   1,504,157
Deferred underwriting commissions
   10,500,000


Total liabilities
   12,004,157
Commitments and Contingencies

Class A ordinary shares; 28,596,845 shares subject to possible redemption at $10.00 per share
   285,968,450
Shareholders’ Equity:

Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
   —
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 1,403,155 shares issued and outstanding (excluding 28,596,845 shares subject to possible redemption)
   140
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,625,000 shares issued and outstanding (1)
   863
Additional paid-in capital
   5,060,460
Accumulated deficit
   (61,454 )


Total shareholders’ equity
   5,000,009


Total Liabilities and Shareholders’ Equity
   $ 302,972,616

~~(1)~~

This number includes up to 1,125,000 Class B ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. Subsequent to September 30, 2020, on October 2, 2020, the underwriters partially exercised the over-allotment option. The underwriters over-allotment option expired ~~45-days~~ ~~from the date of the final prospectus resulting in the 522,897 shares being forfeited~~

SHEETS

June 30, 2022

December 31, 2021


(unaudited)

Assets

Current assets:
Cash    $ 472,528 $ 665,940
Prepaid expenses    36,875 110,626

Total current assets    509,403 776,566
Investments held in Trust Account    324,671,738 324,211,180

Total Assets

$
325,181,141

$
324,987,746


Liabilities, Class A Ordinary Shares Subject to Redemption and Shareholders’ Deficit

Current liabilities:
Accounts payable    $ 412,862 $ 327,477
Accrued expenses    212,001 159,535

Total current liabilities    624,863 487,012
Derivative warrant liabilities    991,435 8,922,920
Deferred underwriting commissions    11,342,945 11,342,945

Total Liabilities
   12,959,243 20,752,877
Commitments and Contingencies
   0 0
Class A ordinary shares subject to possible redemption, $0.0001 par value; 32,408,414 shares issued and outstanding at $10.02 and $10.00 per share redemption value as of June 30, 2022 and December 31, 2021, respectively    324,571,738 324,084,140
Shareholders’ Deficit:

Preference shares, $0.0001 par value; 1,000,000 shares authorized; 0 shares issued or outstanding    0—   0—
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 0
non-redeemable
shares issued or outstanding
   —   —
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,102,103 shares issued and outstanding as of June 30, 2022 and December 31, 2021    810 810
Additional
paid-in
capital
   —   —
Accumulated deficit    (12,350,650 ) (19,850,081 )

Total Shareholders’ Deficit
   (12,349,840 ) (19,849,271 )

Total Liabilities, Class A Ordinary Shares Subject to Redemption and Shareholders’ Deficit

$
325,181,141

$
324,987,746

The accompanying notes are an integral part of these unaudited condensed financial statements.

PRIME IMPACT ACQUISITION I

UNAUDITED CONDENSED ~~STATEMENT~~STATEMENTS OF OPERATIONS

~~FOR THE PERIOD FROM JULY 21, 2020 (INCEPTION) THROUGH SEPTEMBER 30, 2020~~

   For the Period
From July 21, 2020
(Inception) through
September 30, 2020
General and administrative expenses
   $ 50,264
Administrative expenses - related party
   10,000


Loss from operations
   (60,264 )
Interest income
   12
Net loss from investments held in Trust Account
   (1,202 )


Net loss
   (61,454 )


Weighted average Class A ordinary shares outstanding, basic and diluted
   30,000,000


Basic and diluted net loss per ordinary share
   $ 0.00


Weighted average Class B ordinary shares outstanding, basic and diluted (1)
   8,102,103


Basic and diluted net loss per ordinary share
   $ (0.01 )

~~(1)~~

~~This number excludes 522,897 Class B ordinary shares that remain subject to forfeiture as of September 30, 2020 (Note 5). The underwriters over-allotment expired~~ ~~45-days~~ ~~from the date of the final prospectus resulting in the 522,897 shares being forfeited.~~

For the Three Months Ended June 30,

For the Six Months Ended June 30,


2022

2021

2022

2021

General and administrative expenses    $ 81,618 $ 172,449 $ 345,046 $ 664,035
Administrative expenses - related party    30,000 30,000 60,000 60,000
Loss from operations    (111,618 ) (202,449 ) (405,046 ) (724,035 )
Other income (expense)
Change in fair value of derivative warrant liabilities    2,974,307 (2,917,095 ) 7,931,485 9,100,948
Interest income    16 30 33 77
Income from investments held in Trust Account    429,733 11,765 460,557 29,498

Net income (loss)

$
3,292,438

$
(3,107,749
)

$
7,987,029

$
8,406,488

Weighted average Class A ordinary shares outstanding, basic and diluted
   32,408,414 32,408,414 32,408,414 32,408,414

Basic and diluted net income (loss) per Class A ordinary share
   $ 0.08 $ (0.08 ) $ 0.20 $ 0.21

Weighted average Class B ordinary shares outstanding, basic and diluted
   8,102,103 8,102,103 8,102,103 8,102,103

Basic and diluted net income (loss) per Class B ordinary share
   $ 0.08 $ (0.08 ) $ 0.20 $ 0.21

The accompanying notes are an integral part of these unaudited condensed financial statements.

PRIME IMPACT ACQUISITION I

UNAUDITED CONDENSED ~~STATEMENT~~STATEMENTS OF CHANGES IN SHAREHOLDERS’ ~~EQUITY~~

DEFICIT

FOR THE ~~PERIOD FROM JULY 21, 2020 (INCEPTION) THROUGH SEPTEMBER~~THREE AND SIX MONTHS ENDED JUNE 30, ~~2020~~

   Ordinary Shares    Additional
Paid-in
Capital Accumulated
Deficit Total
Shareholders’
Equity
   Class A Class B
   Shares Amount Shares    Amount
Balance - July 21, 2020 (inception)
   —   $ —   —      $ —      $ —   $ —   $ —
Issuance of Class B ordinary shares to Sponsor (1)
   —   —   8,625,000    863    24,137 —   25,000
Sale of units in initial public offering, gross
   30,000,000 3,000 —      —      299,997,000 —   300,000,000
Offering costs
   —   —   —      —      (17,095,087 ) —   (17,095,087 )
Sale of private placement warrants to Sponsor
   —   —   —      —      8,100,000 —   8,100,000
Shares subject to possible redemption
   (28,596,845 ) (2,860 ) —      —      (285,965,590 ) —   (285,968,450 )
Net loss
   —   —   —      —      —   (61,454 ) (61,454 )






Balance - September 30, 2020 (unaudited)
   1,403,155 $ 140 8,625,000    $ 863    $ 5,060,460 $ (61,454 ) $ 5,000,009

~~(1)~~

2022

Ordinary Shares

Additional

Total


Class A

Class B

Paid-in

Accumulated

Shareholders’


Shares

Amount

Shares

Amount

Capital

Deficit

Deficit

Balance - December 31, 2021


—


$
—



8,102,103


$
810


$
—


$
(19,850,081
)

$
(19,849,271
)
Net income    —      —      —      —      —      4,694,591 4,694,591
Increase in redemption value of Class A ordinary shares subject to redemption    —      —      —      —      —      (57,864 ) (57,864 )

Balance - March 31, 2022 (unaudited)


—


$
—



8,102,103


$
810


$
—


$
(15,213,354
)

$
(15,212,544
)
Net income    —      —      —      —      —      3,292,438 3,292,438
Increase in redemption value of Class A ordinary shares subject to redemption    —      —      —      —      —      (429,734 ) (429,734 )

Balance - June 30, 2022 (unaudited)


—


$
—



8,102,103


$
810


$
—


$
(12,350,650
)

$
(12,349,840
)

FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2021

Ordinary Shares

Additional

Total


Class A

Class B

Paid-in

Accumulated

Shareholders’


Shares

Amount

Shares

Amount

Capital

Deficit

Deficit

Balance - December 31, 2020


—


$
—



8,102,103


$
810


$
—


$
(35,618,082
)

$
(35,617,272
)
Net income    —      —      —      —      —      11,514,237 11,514,237

Balance - March 31, 2021 (unaudited)


—


$
—



8,102,103


$
810


$
—


$
(24,103,845
)

$
(24,103,035
)
Net loss    —      —      —      —      —      (3,107,749 ) (3,107,749 )

Balance - June 30, 2021 (unaudited)


—


$
—



8,102,103


$
810


$
—


$
(27,211,594
)

$
(27,210,784
)

The accompanying notes are an integral part of these unaudited condensed financial statements.

PRIME IMPACT ACQUISITION I

UNAUDITED CONDENSED ~~STATEMENT~~STATEMENTS OF CASH FLOWS

~~FOR THE PERIOD FROM JULY 21, 2020 (INCEPTION) THROUGH SEPTEMBER 30, 2020~~

Cash Flows from Operating Activities:

Net loss
   $ (61,454 )
Adjustments to reconcile net loss to net cash used in operating activities:

General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares
   25,000
General and administrative expenses paid by Sponsor under note payable
   100
Net loss from investments held in Trust Account
   1,202
Changes in operating assets and liabilities:

Prepaid expenses
   (410,350 )
Accounts payable
   416,324
Accrued expenses
   2,300


Net cash used in operating activities
   (26,878 )


Cash Flows from Investing Activities:

Cash deposited in Trust Account
   (300,000,000 )


Net cash used in investing activities
   (300,000,000 )


Cash Flows from Financing Activities:

Advance - related party
   900,000
Repayment of note payable to Sponsor
   (98,301 )
Proceeds received from initial public offering, gross
   300,000,000
Proceeds received from private placement
   8,100,000
Offering costs paid
   (6,311,353 )


Net cash provided by financing activities
   302,590,346


Net increase in cash
   2,563,468
Cash - beginning of the period
   —


Cash - ending of the period
   $ 2,563,468


Supplemental disclosure of noncash investing and financing activities:

Offering costs included in accounts payable
   $ 110,533
Offering costs included in accrued expenses
   $ 75,000
Offering costs included in note payable
   $ 98,201
Deferred underwriting commissions
   $ 10,500,000
Initial value of Class A ordinary shares subject to possible redemption
   $ 286,032,440
Change in initial value of Class A ordinary shares subject to possible redemption
   $ 63,990

For the Six Months Ended June 30,


2022

2021

Cash Flows from Operating Activities:

Net income    $ 7,987,029 $ 8,406,488
Adjustments to reconcile net income to net cash used in operating activities:

Change in fair value of derivative warrant liabilities    (7,931,485 ) (9,100,948 )
Net income from investments held in Trust Account    (460,558 ) (29,498 )
Changes in operating assets and liabilities:

Prepaid expenses    73,751 139,974
Accounts payable    85,385 112,465
Accrued expenses    52,466 (3,487 )

Net cash used in operating activities
   (193,412 ) (475,006 )

Cash Flows from Financing Activities:

Repayment of advances from related party    —   (418,317 )

Net cash used in financing activities
   —   (418,317 )

Net change in cash
   (193,412 ) (893,323 )
Cash - beginning of the period
   665,940 1,600,255

Cash - end of the period

$
472,528

$
706,932

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

PRIME IMPACT ACQUISITION I

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Note 1—Description of Organization and Business Operations ~~and Basis of Presentation~~

Prime Impact Acquisition I (the “Company”) ~~is a blank check company~~was incorporated as a Cayman Islands exempted company on July 21, 2020. The Company was incorporated for the purpose of effecting a merger, ~~share~~capital stock exchange, asset acquisition, ~~share~~stock purchase, reorganization or similar business combination with one or more businesses ~~that the Company has not yet identified (“Business~~(the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

As of ~~September~~June 30, ~~2020,~~2022, the Company had not ~~yet~~ commenced any operations. All activity for the period from July 21, 2020 (inception) through ~~September~~June 30, ~~2020~~2022 relates to the Company’s formation and the preparation of the initial public offering described below (the “Initial Public Offering”), and ~~since the closing of~~subsequent to the Initial Public Offering, ~~the search~~identifying a target company for a ~~prospective initial~~ Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company ~~generates~~ will generate

non-operating

income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering. ~~The Company has selected December 31 as its fiscal year end.~~

The Company’s sponsor is Prime Impact Cayman, LLC, a Cayman Islands limited liability company (the “Sponsor”). The registration statement for the Initial Public Offering was declared effective on September 9, 2020. On September 14, 2020, the Company consummated the Initial Public Offering of 30,000,000 units ~~(the~~(each, a “Unit” and collectively, the “Units” and, with respect to the Class A ordinary shares included in the Units, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.1 million, inclusive of approximately $10.5 million in deferred underwriting commissions (Note 6). The underwriters were granted a

45-day

option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. On October 2, 2020, the underwriters partially exercised the over-allotment option to purchase an additional 2,408,414 units (the “Over-Allotment Units”). On October 6, 2020, the Company completed the sale of the Over-Allotment Units to the underwriters (the “Over-Allotment”), generating gross proceeds of approximately $24.1 million, and incurring additional offering costs of approximately $1.3 million in underwriting fees (inclusive of approximately $0.8 million in deferred underwriting commissions).

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 5,400,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) to the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of $8.1 million (Note 4). Simultaneously with the closing of the ~~Over-allotment~~Over-Allotment Units, on October 6, 2020, the Company consummated the second closing of the Private Placement, resulting in the purchase of an ~~aggregate of an~~ additional 321,122 Private Placement Warrants by the Sponsor, generating gross proceeds to the Company of approximately $0.5 million.

Upon the closing of the Initial Public Offering and the Private Placement, ~~$300.0~~$324.1 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering, the Over-Allotment and certain of the proceeds of the Private Placement were placed in a trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and was invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, or the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule

2a-7

promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. ~~Upon closing of the Over-Allotment and the second closing of the Private Placement, an aggregate of approximately $24.1 million ($10.00 per Unit) was placed in the Trust Account.~~

The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account ~~(as defined below)~~ (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting discount) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company

will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.

Table of Contents

PRIME IMPACT ACQUISITION I

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

The Company will provide its holders of the Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The

per-share

amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares will be recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from ~~Equity.”~~Equity” (“ASC 480”). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which will be adopted by the Company upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”), and file tender offer documents with the SEC prior to completing a Business Combination. If, however, a shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the holders of the Founder Shares (as defined in Note 5) prior to this Initial Public Offering (the “Initial Shareholders”) have agreed to vote their Founder Shares ~~(as defined in Note 5)~~ and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Initial Shareholders have agreed to waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of a Business Combination. In addition, the Company has agreed not to enter into a definitive agreement regarding an initial Business Combination without the prior consent of the Sponsor.

Notwithstanding the foregoing, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% or more of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company.

The Company’s Sponsor, executive officers, directors and director nominees have agreed not to propose an amendment to the Company’s Amended and Restated Memorandum and Articles of Association that would affect the substance or timing of the Company’s obligation to provide for the redemption of its Public Shares in connection with a Business Combination or to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.

If the Company is unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or September 14, 2022 (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a

per-share

distributions, if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject, in the case of clauses (ii) and (iii), to the Company’s obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law.

Table of Contents

PRIME IMPACT ACQUISITION I

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

In connection with the redemption of 100% of the Company’s outstanding Public Shares for a portion of the funds held in the Trust Account, each holder will receive a full pro rata portion of the amount then in the Trust Account, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay the Company’s taxes payable (less up to $100,000 of interest to pay dissolution expenses).

The Initial Shareholders have agreed to waive their liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Company’s Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

Note 2—Basis of Presentation

and Summary of Significant Accounting Policies

Basis of Presentation

The accompanying ~~unaudited~~ condensed financial statements of the Company have been prepared in accordance with United States generally accepted accounting principles (“~~U.S.~~ GAAP”) for interim financial information and Article 810 of Regulation

S-X.

Accordingly, certain disclosures included in the annual financial statements have been condensed or omitted from these condensed financial statements as they doare not ~~include all~~required for interim financial statements under GAAP and the rules of the ~~information~~Securities and ~~footnotes required by U.S. GAAP.~~Exchange Commission. In the opinion of management, all adjustments (consisting of normal accruals) considered for a fair presentation have been included. Operating results for the ~~period from July 21, 2020 (inception) through September~~three and six months ended June 30, ~~2020~~2022 are not necessarily indicative of the results that may be expected for the ~~period~~year ending December 31, ~~2020.~~

2022 or any future period.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form

10-K

for the year ended December 31, 2021, as filed with the SEC on March 21, 2022, which contains the audited financial statements and notes ~~thereto included~~thereto. The financial information as of December 31, 2021, is derived from the audited financial statements presented in the Company’s Annual Report on Form~~8-K~~ ~~and~~

10-K

for the ~~final prospectus~~year ended December 31, 2021, as filed ~~by the Company~~ with the SEC on March 21, 2022.

Table of Contents

PRIME IMPACT ACQUISITION I

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Liquidity and Going Concern

As of June 30, 2022, the Company had approximately $0.5 million in its operating bank account and working capital deficit of approximately $115,000.

Prior to the completion of the Initial Public Offering, the Company’s liquidity needs had been satisfied through the payment of $25,000 from the Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares, a loan of approximately $98,000 pursuant to the Note (as defined in Note 5) issued to the Sponsor (Note 5). The Company repaid the Note in full on September ~~18, 2020~~16, 2020. Subsequent to the consummation of the Initial Public Offering and Private Placement, the Company’s liquidity needs have been satisfied with the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor may, but is not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of June 30, 2022 and December 31, 2021, there were 0 amounts outstanding under any Working Capital Loans.

The Company’s management plans to continue its efforts to complete a Business Combination within 24 months of the closing of the Initial Public Offering, or September ~~11, 2020, respectively.~~

14, 2022. The Company believes that the funds currently available to it outside of the Trust Account will be sufficient to allow it to operate until September 14, 2022; however, there can be no assurances that this estimate is accurate.

In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic
205-40,
“Presentation of Financial Statements—Going Concern,” management has determined that the liquidity concerns, mandatory liquidation date and subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. If the Company is unable to complete a business combination by September 14, 2022, then the Company will cease all operations except for the purpose of liquidating. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after September 14, 2022.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the ~~auditor~~independent registered public accounting firm attestation requirements of Section 404 of

the Sarbanes-Oxley Act, ~~of 2002,~~ reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to

non-emerging

growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make comparison of the Company’s condensed financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

~~Risk and Uncertainties~~

~~On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the~~ ~~“COVID-19~~ ~~outbreak”). In March 2020, the WHO classified the~~ ~~COVID-19~~ ~~outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the~~ ~~COVID-19~~ ~~outbreak continues to evolve. The impact of the~~ ~~COVID-19~~ outbreak on the Company’s results of operations, financial position and cash flows will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact of the ~~COVID-19~~ outbreak on the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Company’s results of operations, financial position and cash flows may be materially adversely affected. Additionally, the Company’s ability to complete an Initial Business Combination may be materially adversely affected due to significant governmental measures being implemented to contain the ~~COVID-19~~ outbreak or treat its impact, including travel restrictions, the shutdown of businesses and quarantines, among others, which may limit the Company’s ability to have meetings with potential investors or affect the ability of a potential target company’s personnel, vendors and service providers to negotiate and consummate an Initial Business Combination in a timely manner. The Company’s ability to consummate an Initial Business Combination may also be dependent on the ability to raise additional equity and debt financing, which may be impacted by the ~~COVID-19~~ ~~outbreak and the resulting market downturn.~~

~~Liquidity and Capital Resources~~

~~As of September 30, 2020, the Company had $2.6 million in its operating bank account, and working capital of approximately $1.5 million.~~

Prior to the completion of the Initial Public Offering, the Company’s liquidity needs had been satisfied through the payment of $25,000 from the Sponsor to cover certain expenses in exchange for the issuance of the Founder Shares (as defined in Note 5), a loan of approximately $98,000 pursuant to the Note issued to the Sponsor (Note 5). The Company repaid the Note in full on September 16, 2020. Subsequent to the consummation of the Initial Public Offering and Private Placement, the Company’s liquidity needs have been satisfied with the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor may, but is not obligated to, provide the Company Working Capital Loans (see Note 5). As of September 30, 2020, there were no amounts outstanding under any Working Capital Loan.

Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity from the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying

and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

~~Management continues to evaluate the impact of the~~ ~~COVID-19~~ pandemic and has concluded that the specific impact is not readily determinable as of the date of the balance sheet. The financial statements does not include any adjustments that might result from the outcome of this uncertainty.

~~Note 2—Summary of Significant Accounting Policies~~

Use of Estimates

The preparation of these condensed financial statements in conformity with ~~U.S.~~ GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial ~~statements and the reported amounts of expenses during the reported period.~~

statements. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a

Table of Contents

PRIME IMPACT ACQUISITION I

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

condition, situation or set of circumstances that existed at the date of the condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

One of the more significant accounting estimates included in these condensed financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.

~~Investment Securities~~ As of June 30, 2022 and December 31, 2021, there were no cash equivalents held outside of the Trust Account.

Concentration of Credit Risk

$250,000. As of June 30, 2022 and December 31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements,” approximates the carrying amounts represented in the condensed balance sheets, other than investments held in Trust Account and derivative warrant liabilities, both of which are described below.

Investments Held in Trust Account

The Company’s portfolio of investments is comprised ~~solely~~ of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. ~~The~~When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance ~~sheet~~sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in ~~net gain or loss on~~income from investments held in Trust Account in the accompanying unaudited condensed ~~statement~~statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.

~~Concentration of Credit Risk~~

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000, and investments held in Trust Account. At September 30, 2020, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Fair Value ~~of Financial Instruments~~

Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. ~~U.S.~~ GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value.

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

Table of Contents

PRIME IMPACT ACQUISITION I

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

Derivative Warrant Liabilities

The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of ~~September 30, 2020,~~its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and FASB ASC Topic 815, “Derivatives and Hedging” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is

re-assessed

at the ~~carrying values~~end of ~~cash, accounts payable, accrued expenses~~each reporting period. Derivative warrant liabilities are classified as

non-current

liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

The warrants issued in connection with the Initial Public Offering (the “Public Warrants”) and ~~note payable – related party approximate their~~the Private Placement Warrants are recognized as derivative liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair ~~values due~~value and adjusts the instruments to ~~the short-term nature of the instruments.~~fair value at each reporting period. The ~~Company’s portfolio of investments held~~liabilities are subject to

re-measurement

at each balance sheet date until exercised, and any change in fair value is recognized in the ~~Trust Account is comprised~~Company’s unaudited condensed statements of ~~investments in U.S. Treasury securities with an original maturity of 185 days or less or investments in money market funds that invest in U.S. government securities, or a combination thereof.~~operations. The fair value ~~for trading securities is determined~~of the Public Warrants issued in connection with the Public Offering and Private Placement Warrants were initially measured at fair value using ~~quoted~~a Monte Carlo simulation model and subsequently, the fair value of the Private Placement Warrants have been estimated using a Monte Carlo simulation model each measurement date. The fair value of Public Warrants issued in connection with the Initial Public Offering have subsequently been measured based on the listed market ~~prices in active markets.~~

price of such warrants.

Offering Costs Associated with the Initial Public Offering

The Company complies with the requirements of the FASB ASC Topic

340-10-S99-1

and SEC Staff Accounting Bulletin Topic

5A-“Expenses

of Offering.” Offering costs consisted of legal, accounting, underwriting ~~fees~~commissions and other costs incurred that were directly related to the Initial Public Offering. Offering ~~and that~~costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as

non-operating

expenses in the unaudited condensed statements of operations. Offering costs associated with the Public Shares were charged against the carrying value of the Class A ordinary shares subject to ~~shareholders’ equity~~possible redemption upon the completion of the Initial Public Offering.

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC ~~Topic 480 “Distinguishing Liabilities from Equity.”~~480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, ~~at September~~as of June 30, ~~2020, 28,596,845~~2022 and December 31, 2021, an aggregate of 32,408,414 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ ~~equity~~deficit section of the Company’s ~~unaudited~~ condensed balance ~~sheet.~~

sheets.

Effective with the closing of the Initial Public Offering (including exercise of the over-allotment option), the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional
paid-in
capital (to the extent available) and accumulated deficit.

Table of Contents

PRIME IMPACT ACQUISITION I

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Income Taxes

FASB ASC Topic 740, ~~Income~~“Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no0 unrecognized tax benefits as of ~~September~~June 30, ~~2020.~~2022 and December 31, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. NoNaN amounts were accrued for the payment of interest and penalties as of ~~September~~June 30, ~~2020.~~2022 and December 31, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s ~~unaudited~~ condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Net Income (Loss) Per Ordinary Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is ~~computed~~calculated by dividing the net income (loss), adjusted for the effects of a deemed dividend to Class A shareholders, by the ~~weighted-average number of~~weighted average ordinary shares outstanding ~~during~~for the ~~periods.~~ respective period.

The ~~Company has~~calculation of diluted net income per ordinary share does not ~~considered~~consider the effect of the warrants ~~sold~~issued in connection with the Initial Public Offering (including exercise of the over-allotment option) and the Private Placement to purchase an aggregate of ~~15,400,000, of the Company’s Class A~~16,523,926 ordinary shares in the calculation of diluted income per share, ~~since~~because their exercise is contingent upon future events and their inclusion would be anti-dilutive under the treasury stock method.

~~The Company’s unaudited condensed statement of operations includes~~ As a ~~presentation of~~result, diluted net income (loss) per share is the same as basic net income (loss) per share for ~~ordinary shares subject to redemption in a manner similar to~~ the ~~two-class~~ ~~method of income per share. Net loss per ordinary share, basic~~three and ~~diluted for~~six months ended June 30, 2022 and 2021. The initial accretion associated with the redeemable Class A ordinary shares ~~are calculated by dividing~~is excluded from earnings per share as the ~~loss recognized on investments held in the Trust Account by the weighted average number~~redemption value approximates fair value. Subsequent periods accretion of Class A ordinary shares ~~outstanding for~~subject to possible redemption is recognized as a deemed dividend to shareholders in the ~~period. Net loss~~calculation of the net income per ordinary ~~share,~~share.

The following table presents a reconciliation of the numerator and denominator used to compute basic and diluted net income per share for ~~Class B~~each class of ordinary ~~shares is calculated by dividing the net loss, less loss attributable to Class A ordinary shares by the weighted average number of Class B ordinary shares outstanding for the period.~~

share:

For the Three Months Ended June 30,

For the Six Months Ended June 30,

2022

2021

2022

2021

Class A

Class B

Class A

Class B

Class A

Class B

Class A

Class B

Basic and diluted net income (loss) per ordinary share:
Numerator:
Allocation of net income (loss) available to ordinary shareholders $ 2,633,950 $ 658,488 $ (2,486,199 ) $ (621,550 ) $ 6,389,623 $ 1,597,406 $ 6,725,190 $ 1,681,298
Denominator:
Basic and diluted weighted average ordinary shares outstanding 32,408,414 8,102,103 32,408,414 8,102,103 32,408,414 8,102,103 32,408,414 8,102,103

Basic and diluted net income (loss) per
ordinary share
$ 0.08 $ 0.08 $ (0.08) $ (0.08) $ 0.20 $ 0.20 $ 0.21 $ 0.21

Recent Accounting Pronouncements

Management does not believe that any recently issued, but not yet effective, accounting ~~pronouncement~~standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.

Table of Contents

PRIME IMPACT ACQUISITION I

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Note ~~3—Initial~~

3-Initial

Public Offering

On September 14, 2020, the Company consummated the Initial Public Offering of 30,000,000 units, at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.1 million, inclusive of approximately $10.5 million in deferred underwriting commissions. The underwriters were granted a

45-day

option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. On October 2, 2020, the underwriters partially exercised the ~~over-allotment~~Over-Allotment option to purchase an additional 2,408,414 units and on October 6, 2020, the Company completed the sale of the Over-Allotment Units to the underwriters, generating gross proceeds of approximately $24.1 million, and incurring additional offering costs of approximately $1.3 million in underwriting fees (inclusive of approximately $0.8 million in deferred underwriting commissions).

Each Unit consists of one Class A ordinary share and

one-third

of one redeemable ~~warrant (“Public Warrant”).~~warrant. Each whole Public Warrant will entitle the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 7).

Note ~~4—Private~~

4-Private

Placement

Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement with the purchase of 5,400,000 Private Placement Warrants toby the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of $8.1 million. ~~If the over-allotment option is exercised, the Sponsor will purchase an additional amount of up to 600,000 Private Placement Warrants at a price of $1.50 per Private Placement Warrant.~~ Simultaneously with the closing of the ~~Over-allotment~~Over-Allotment Units, on October 6, 2020, the Company consummated the second closing of the Private Placement, resulting in the purchase of an aggregate of an additional 321,122 Private Placement Warrants by the Sponsor, generating gross proceeds to the Company of approximately $0.5 million.

Each whole Private Placement Warrant is exercisable for one whole Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Sponsor was added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be

non-redeemable

for cash and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees.

The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.

Note ~~5—Related~~

5-Related

Party Transactions

Founder Shares

On July 23, 2020, the Sponsor paid an aggregate of $25,000 for certain expenses on behalf of the Company in exchange for issuance of 8,625,000 Class B ordinary shares (the “Founder Shares”). The holders of the Founder Shares ~~have~~ agreed to forfeit up to an aggregate of 1,125,000 Founder Shares, on a pro rata basis, to the extent that the option to purchase additional units iswas not exercised in full by the underwriters, so that the Founder Shares ~~will~~would represent 20% of the Company’s issued and outstanding shares after the Initial Public Offering. On September 3, 2020, the Sponsor transferred 20,000 Founder Shares to each of Cathleen Benko, Roger Crockett, Dixon Doll, Keyur Patel and Joanna Strober. Such Founder Shares ~~will~~are not be subject to forfeiture in the event the underwriters’ ~~over-allotment is~~Over-Allotment was not exercised. On October 2, 2020, the underwriters partially exercised the ~~over-allotment~~Over-Allotment option to purchase as additional 2,408,414 Units. On October 24, ~~2022~~2020 (the 45^th45th day follow the Underwriting Agreement), 522,897 Class B ordinary shares were forfeited.

The Initial Shareholders agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share

sub-divisions,

share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any

30-trading

day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of the Sponsor and the Company’s founding team with respect to any Founder Shares, Private Placement Warrants and Class A

Table of Contents

PRIME IMPACT ACQUISITION I

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

ordinary shares issued upon conversion or exercise thereof. Notwithstanding the foregoing, if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share

sub-divisions,

share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any

30-trading

day period commencing at least 150 days after the initial Business Combination, the Founder Shares will be released from the

lock-up.

Related Party Loans

On July 23, 2020, the Sponsor had agreed to loan the Company up to $300,000 to be used for the payment of costs related to the Initial Public Offering pursuant to a promissory note (the “Note”). The Note was ~~non-interest~~ bearing, unsecured and due upon the closing of the Initial Public Offering. The Company had borrowed approximately $98,000 under the Note and repaid the balance owed under the on September 16, 2020.

In ~~addition, in~~ order to finance transaction costs in connection with a Business Combination, the Sponsor, members of the Company’s founding team or any of their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company ~~would~~will repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.

The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of ~~September~~June 30, ~~2020,~~2022 and December 31, 2021, the Company had no borrowings under the Working Capital Loans.

~~The Company received extra funding of $900,000 to purchase up to 600,000 Private Placement Warrants if the over-allotment option is exercised in full.~~

Administrative Services Agreement

The Company entered into an agreement that provided that, commencing on the date that the Company’s securities are first listed on the ~~NYSE~~New York Stock Exchange through the earlier of consummation of the initial Business Combination or the Company’s

liquidation, the Company will pay the Sponsor $10,000 per month for office space, secretarial and administrative services. The Company incurred ~~$10,000~~$30,000 and $30,000 in expenses in connection with such services during the ~~period from July 21, 2020 (inception) through September~~three months ended June 30, ~~2020~~2022 and 2021, respectively, as reflected in the administrative expenses-related party on the accompanying unaudited condensed ~~statement~~statements of operations. The Company incurred $60,000 and $30,000 in expenses in connection with such services during the six months ended June 30, 2022 and 2021, respectively, as reflected in the administrative expenses-related party on the accompanying unaudited condensed statements of operations. As of ~~September~~June 30, ~~2020,~~2022 and December 31, 2021, the Company had ~~approximately $10,000~~$215,000 and $155,000, respectively, in ~~accounts payable~~accrued expenses in connection with such services as reflected in the accompanying ~~unaudited~~ condensed balance ~~sheet.~~

sheets.

In addition, the Sponsor, executive officers and directors, or any of their respective affiliates will be reimbursed for any

out-of-pocket

expenses incurred in connection with activities on the Company’s behalf such as identifying potential partner businesses and performing due diligence on suitable Business Combinations. The Company’s audit committee will review on a quarterly basis all payments that were made by the Company to the Sponsor, executive officers or directors of the Company’s or their affiliates. Any such payments prior to an initial Business Combination will be made using of funds held outside the Trust Account.

Note ~~6—Commitments~~

6-Commitments

and Contingencies

Risk and Uncertainties

On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the
“COVID-19
outbreak”). In March 2020, the WHO classified the
COVID-19
outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the
COVID-19
outbreak continues to evolve. The impact of the
COVID-19
outbreak on the Company’s results of operations, financial position and cash flows will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact of the
COVID-19
outbreak on the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Company’s results of operations, financial position and cash flows may be materially adversely affected. Additionally, the Company’s ability to complete an initial Business Combination may

Table of Contents

PRIME IMPACT ACQUISITION I
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
be materially adversely affected due to significant governmental measures being implemented to contain the
COVID-19
outbreak or treat its impact, including travel restrictions, the shutdown of businesses and quarantines, among others, which may limit the Company’s ability to have meetings with potential investors or affect the ability of a potential target company’s personnel, vendors and service providers to negotiate and consummate an initial Business Combination in a timely manner. The Company’s ability to consummate an Initial Business Combination may also be dependent on the ability to raise additional equity and debt financing, which may be impacted by the
COVID-19
outbreak and the resulting market downturn.

Registration and Shareholder Rights

The holders of the Founder Shares, Private Placement Warrants, Class A ordinary shares underlying the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans) are entitled to registration rights pursuant to a registration and shareholder rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters a

45-day

option from the date of ~~this~~the prospectus to purchase up to 4,500,000 additional Units at the Initial Public Offering price less the underwriting discounts and commissions. On October 2, 2020, the underwriters partially exercised the ~~over-allotment~~Over-allotment option to purchase an additional 2,408,414 ~~units.~~

Units.

The underwriters were entitled to an underwriting discount of $0.20 per ~~unit,~~Unit, or $6.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $10.5 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

If the option to purchase additional units iswas exercised in full, the underwriters ~~will be~~would have been entitled to an aggregate of $900,000 in fees payable upon closing and additional deferred underwriting commissions of approximately $1.6 million. On October 2, 2020, the ~~over-allotment~~Over-Allotment option was partially exercised, resulting in an underwriting discount of approximately $0.5 million deducted from the proceeds received for sale of the Over-Allotment Units, and approximately $0.8 million of deferred underwriting commissions.

Note ~~7—Shareholders’ Equity~~

~~Class~~ ~~A Ordinary Shares~~~~—The~~

7-Derivative

Warrant Liabilities

As of June 30, 2022 and December 31, 2021, the Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. At September 30, 2020, there were 30,000,000 Class A ordinary shares issued or outstanding, including 28,596,845 Class A ordinary shares subject to possible redemption.

~~Class~~ ~~B Ordinary Shares~~—The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. On September 30, 2020, 8,625,000 Class B ordinary shares were issued and outstanding includinghad an aggregate of up to 1,125,000 Class B ordinary shares that are subject to forfeiture, to the Company by the Initial Shareholders for no consideration to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the Initial Shareholders will collectively own 20%16,523,926 warrants outstanding, comprised of ~~the Company’s issued~~10,802,804 Public Warrants and ~~outstanding ordinary shares after the Initial Public Offering. On October 24, 2022 (the 45~~^th ~~day follow the Underwriting Agreement), 522,897 Class B ordinary shares were forfeited.~~

Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law.

The Class B ordinary shares will automatically convert into Class A ordinary shares immediately upon the consummation of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an ~~as-converted~~ basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any5,721,122 Private Placement Warrants issued to the Sponsor, members of the Company’s founding team or any of their affiliates upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one to one.

~~Preference Shares~~~~—The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share. At September 30, 2020, there were no preference shares issued or outstanding.~~

~~Warrants~~—Warrants.

Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder (or the Company permit holders to exercise their warrants on a cashless basis under certain circumstances). The Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC and have an effective registration statement covering the Class A ordinary shares issuable upon exercise of the warrants and to maintain a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the 60th day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective

Table of Contents

PRIME IMPACT ACQUISITION I

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

The warrants have an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional Class A ordinary shares or equity linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), or the ~~Newly~~“Newly Issued Price,” (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial

Business Combination (net of redemptions), and (z) the volume-weighted average trading price of the ordinary shares during the 20 trading day period starting on the trading day after the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $10.00 and 18.00 per share redemption trigger prices described below under “Redemption of warrants when the price per Class A ordinary share equal or exceed $10.00” and “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 100% and 180% of the higher of the Market Value and the Newly Issued Price, respectively.

The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A ordinary shares issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be

non-redeemable

so long as they are held by the initial purchasers or such purchasers’ permitted transferees. If the Private Placement Warrants are held by someone other than the Initial Shareholders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

Redemption of warrants for cash when the price per Class A ordinary share equals or exceeds $18.00: Once the warrants become exercisable, the Company may call the outstanding warrants for redemption (except as described herein with respect to the Private Placement Warrants):

in whole and not in part;

at a price of $0.01 per warrant;

upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and

if, and only if, the last reported sales price (the “closing price”) of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share

sub-divisions,

share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a

30-trading

day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders (the “Reference Value”).

Redemption of warrants for Class A ordinary shares when the price per Class A ordinary share equals or exceeds $10.00: Once the warrants become exercisable, the Company may redeem the outstanding warrants:

in whole and not in part;

•

~~at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption;~~ ~~provided~~ that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of the Class A ordinary shares;

Table of Contents

PRIME IMPACT ACQUISITION I

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to an agreed table based on the redemption date and the “fair market value” of the Class A ordinary shares;

if, and only if, the Reference Value equals or exceeds $10.00 per Public Share (as adjusted per share

sub-divisions,

share dividends, reorganizations, recapitalizations and the like); and

if the Reference Value is less than $18.00 per share (as adjusted for share

sub-divisions,

share dividends, rights issuances,

sub-divisions,

reorganizations, recapitalizations and the like), then the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants as described above.

The Company will not redeem the warrants as described above unless an effective registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the warrants is effective and a current prospectus relating to those Class A ordinary shares is available throughout the

30-day

redemption period. Any such exercise would not be on a “cashless” basis and would require the exercising warrant holder to pay the exercise price for each warrant being exercised.

The “fair market value” of Class A ordinary shares for the above purpose shall mean the volume-weighted average price of the Class A ordinary shares for the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361 Class A ordinary shares per warrant (subject to adjustment).

~~In no event will the Company be required to net cash settle any warrant.~~

If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

Note

8-Class

A Ordinary Shares Subject to Possible Redemption

The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 200,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. As of June 30, 2022 and December 31, 2021, there were 32,408,414 Class A ordinary shares outstanding, which were all subject to possible redemption and are classified outside of permanent equity in the condensed balance sheets.

The Class A ordinary shares subject to possible redemption reflected on the condensed balance sheets are reconciled on the following table:


Gross proceeds	$	324,084,140
Less:
Amount allocated to Public Warrants		(12,955,337	)
Class A ordinary shares issuance costs		(17,680,825	)
Plus:
Accretion of carrying value to redemption value		30,636,162

Class A ordinary shares subject to possible redemption, December 31, 2021		324,084,140
Increase in redemption value of Class A ordinary shares subject to redemption		57,864

Class A ordinary shares subject to possible redemption, March 31, 2022		324,142,004
Increase in redemption value of Class A ordinary shares subject to redemption		429,733

Class A ordinary shares subject to possible redemption, June 30, 2022	$	324,571,738

Table of Contents

PRIME IMPACT ACQUISITION I

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Note

9-Shareholders’

Deficit

Preference Shares-

The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share. As of June 30, 2022 and December 31, 2021, there were 0 preference shares issued or outstanding.

Class

A Ordinary Shares-

The Company is authorized to issue 200,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of June 30, 2022 and December 31, 2021, there were 32,408,414 Class A ordinary shares issued and outstanding, all of which are subject to possible redemption and therefore classified as temporary equity in the accompanying condensed balance sheets (see Note ~~8—Fair~~ 8).

Class

B Ordinary Shares-

The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. As of June 30, 2022 and December 31, 2021, 8,102,103 Class B ordinary shares were issued and outstanding. Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law.

as-converted

basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, members of the Company’s founding team or any of their affiliates upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one to one.

Note

10-Fair

Value Measurements

The following ~~table presents~~tables present information about the Company’s financial assets and liabilities that are measured at fair value on a recurring basis as of ~~September~~June 30, ~~2020~~2022 and ~~indicates~~December 31, 2021 by level within the fair value ~~hierarchy~~hierarchy:


	As of June 30, 2022
Description	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)

Assets:
Investments held in Trust Account - U.S. Treasury Securities	$	324,671,738	$	—	$	—
Liabilities:
Derivative warrant liabilities-Public warrants	$	648,168	$	—	$	—
Derivative warrant liabilities-Private placement warrants	$	—	$	—	$	343,267


	As of December 31, 2021
Description	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)

Assets:
Investments held in Trust Account - U.S. Treasury Securities	$	324,211,180	$	—	$	—
Liabilities:
Derivative warrant liabilities - Public warrants	$	5,833,514	$	—	$	—
Derivative warrant liabilities - Private placement warrants	$	—	$	—	$	3,089,406

Table of ~~the valuation techniques that the Company utilized to determine such fair value.~~

   Quoted Prices in
Active Markets    Significant Other
Observable Inputs    Significant Other
Unobservable Inputs
Description
   (Level 1)    (Level 2)    (Level 3)
Assets held in Trust Account:

U.S. Treasury Securities
   $ 299,992,977    $ —      $ —
Cash equivalents – money market funds
   5,082    —      —






   $ 299,998,798    $ —      $ —

Contents

PRIME IMPACT ACQUISITION I

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Transfers to/from Levels 1, 2, and 3 are recognized at the ~~end~~beginning of the reporting period. There were no transfers between levels ~~for~~of the ~~period from July 21, 2020 (inception) through September~~hierarchy during the

six-month

periods ending June 30, ~~2020.~~

2022 and 2021.

Level 1 ~~instruments~~assets include investments in U.S. Treasury securities or money market funds ~~and~~that invest solely in U.S. Treasury securities. The Company uses inputs such as actual trade data, benchmark yields, quoted market prices from dealers or brokers, and other similar sources to determine the fair value.

The fair value of the Public Warrants is measured based on the listed market price of such warrants, a Level 1 measurement. The estimated fair value of the Private Placement Warrant is based on a Monte Carlo simulation, which includes use of some Level 3 inputs. Inherent in a Monte Carlo simulation are assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ~~investments.~~

Class A ordinary shares warrants based on implied volatility from the Company’s traded warrants and from historical volatility of select peer company’s Class A ordinary shares that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury

zero-coupon

yield curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero.

The following table provides quantitative information regarding Level 3 fair value measurements inputs at their measurement dates:


	June 30, 2022			December 31, 2021

Exercise price	$	11.50		$	11.50
Stock price	$	10.00		$	9.84
Volatility		6.3	%		9.3	%
Term		5.46			5.58
Risk-free rate		2.97	%		1.30	%
Dividend yield		0.0	%		0.0	%

The change in the fair value of the derivative warrant liabilities measured with Level 3 inputs for the three and six months ended June 30, 2022 and 2021 is summarized as follows:


	2022			2021

Level 3 derivative warrant liabilities at January 1,	$	3,089,406		$	9,096,584
Change in fair value of derivative warrant liabilities		(1,716,337	)		(4,348,053	)

Level 3 derivative warrant liabilities at March 31,	$	1,373,069		$	4,748,531
Change in fair value of derivative warrant liabilities		(1,029,802	)		972,591

Level 3 derivative warrant liabilities at June 30, 2022	$	343,267		$	5,721,122

Note 9—10—Subsequent Events

The Company evaluated subsequent events and transactions that occurred after the condensed balance sheet date up to the date that the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events ~~other than described in Notes 1, 6 and 7,~~ that would have required adjustment or disclosure in the unaudited condensed financial statements.

Table of Contents

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

References to the “Company,” “Prime Impact Acquisition I,” “Prime Impact,” “our,” “us” or “we” refer to Prime Impact Acquisition I. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form
10-Q
includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the ~~Securities~~ Exchange Act of 1934 ~~as amended~~ (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Such statements include, but are not limited to, possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this Form 10-Q. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other U.S. Securities and Exchange Commission ~~(“SEC”~~(the “SEC”) filings.

Overview

We are a blank check company incorporated ~~on July 21, 2020~~ as a Cayman Islands exempted company on July 21, 2020. We were formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”) ~~that~~. We are an emerging growth company and, as such, we ~~have not yet identified.~~ are subject to all of the risks associated with emerging growth companies.

Our sponsor is Prime Impact Cayman, LLC, a Cayman Islands limited liability company ~~(our~~(the “Sponsor”).

~~Our~~ The registration statement for ~~our~~the initial public offering ~~(the “Initial Public Offering”)~~ was declared effective on September 9, ~~2020.~~2020 (the “Initial Public Offering”). On September 14, 2020, we consummated the Initial Public Offering of 30,000,000 units ~~(the~~(each, a “Unit” and collectively, the “Units” and, with respect to the Class A ordinary shares included in the Units, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $300.0 million, and incurring offering costs of approximately $17.1 million, inclusive of approximately $10.5 million in deferred underwriting commissions. The underwriters were granted a

45-day

option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any, at $10.00 per Unit. On October 2, 2020, the underwriters partially exercised the over-allotment option to purchase an additional 2,408,414 units (the “Over-Allotment Units”). On October 6, 2020, we completed the sale of the Over-Allotment Units to the underwriters (the “Over-Allotment”), generating gross proceeds of approximately $24.1 million, and incurring additional offering costs of approximately $1.3 million in underwriting fees (inclusive of approximately $0.8 million in deferred underwriting commissions).

Simultaneously with the closing of the Initial Public Offering, we consummated the private placement (“Private Placement”) of 5,400,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) to ~~our~~the Sponsor, each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $1.50 per Private Placement Warrant, generating gross proceeds to us of $8.1 million. Simultaneously with the closing of the Over-allotment Units, on October 6, 2020, we consummated the second closing of the Private Placement, resulting in the purchase of an ~~aggregate of an~~ additional 321,122 Private Placement Warrants by ~~our~~the Sponsor, generating gross proceeds to us of approximately $0.5 million.

Table of Contents

Company Act of 1940, as amended, or the Investment Company Act, having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule

2a-7

promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by us, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. ~~Upon closing~~

Our management has broad discretion with respect to the specific application of the ~~Over-Allotment~~net proceeds of its Initial Public Offering and the ~~second closing~~sale of Private Placement Warrants, although substantially all of the ~~Private Placement, an aggregate~~net proceeds are intended to be applied generally toward consummating a Business Combination. Our initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of ~~approximately $24.1 million ($10.00 per Unit) was placed~~the net assets held in the Trust ~~Account.~~

Account (net of amounts disbursed to management for working capital purposes, if permitted, and excluding the amount of any deferred underwriting discount) at the time we sign a definitive agreement in connection with the initial Business Combination. However, we will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.

If we are unable to complete a Business Combination within 24 months from the closing of the Initial Public Offering, or September 14, 2022 (the “Combination Period”), we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a

per-share

price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any) and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and ~~our~~the board of directors, liquidate and dissolve, subject, in the case of clauses (ii) and (iii), to our obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law.

Liquidity and Going Concern

As of June 30, 2022, we had approximately $0.5 million in our operating bank account and working capital deficit of approximately $115,000.

Prior to the completion of the Initial Public Offering, our liquidity needs had been satisfied through the payment of $25,000 from the Sponsor to cover certain expenses in exchange for the issuance of Class B ordinary shares and a loan of approximately $98,000 pursuant to a promissory note issued to the Sponsor. We repaid the promissory note in full on September 16, 2020. Subsequent to the consummation of the Initial Public Offering and Private Placement, our liquidity needs have been satisfied with the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor may, but is not obligated to, provide us Working Capital Loans. As of June 30, 2022 and December 31, 2021, there were no amounts outstanding under any Working Capital Loans.

In connection with our assessment of going concern considerations in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic

205-40,

“Presentation of Financial Statements-Going Concern,” our management has determined that the mandatory liquidation date and subsequent dissolution raises substantial doubt about our ability to continue as a going concern. If we are unable to complete a business combination within 24 months of the closing of the Initial Public Offering, or September 14, 2022, then we will cease all operations except for the purpose of liquidating. No adjustments have been made to the carrying amounts of assets or liabilities should we be required to liquidate after September 14, 2022. Our management plans to continue its efforts to complete a Business Combination by September 14, 2022. We believe that the funds currently available to us outside of the Trust Account will be sufficient to allow us to operate until September 14, 2022; however, there can be no assurances that this estimate is accurate.

Management continues to evaluate the impact of the

COVID-19

pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on our financial position, results of our operations and/or search for a target company, the specific impact is not readily determinable as of the date of the condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Table of Contents

Results of Operations

Our entire activity since inception through ~~September~~June 30, ~~2020~~2022, related to our formation, the preparation for the Initial Public Offering, and since the closing of the Initial Public Offering, the search for a prospective initial Business Combination. We have neither engaged in any operations nor generated any revenues to date. We will not generate any operating revenues until after completion of our initial Business Combination. We ~~will generate~~ generated

non-operating

income in the form of investment income from the investments held in the Trust Account following the closing of the Initial Public Offering.

For the three months ended June 30, 2022, we had a net income of approximately $3.3 million, which consisted of a

non-operating

gain of approximately $3.0 million from the changes in fair value of derivative warrant liabilities and approximately $430,000 in interest income ~~on cash~~from investments held in the Trust Account, partially offset by approximately $82,000 in general and ~~cash equivalents. We expect to incur increased~~administrative expenses ~~as a result of being a public company (for legal, financial reporting, accounting~~ and ~~auditing compliance), as well as for due diligence expenses.~~

$30,000 in administrative expenses—related party.

For the ~~period from July 21, 2020 (inception) through September~~three months ended June 30, ~~2020,~~2021, we had a net loss of approximately ~~$61,400,~~$3.1 million, which consisted of approximately ~~$60,200~~$172,000 in general and administrative ~~costs~~expenses, approximately $30,000 in administrative expenses—related party, and a loss of approximately ~~$1,200 net loss on~~$2.9 million from the change in fair value of derivative warrant liabilities, which was partially offset by approximately $12,000 income from investments held in the Trust Account.

~~Liquidity and Capital Resources~~

~~As of September~~

For the six months ended June 30, ~~2020,~~2022, we had ~~approximately $2.6 million in our operating bank account, working capital~~a net income of approximately ~~$1.5~~$8.0 million, which consisted of a

non-operating

gain of approximately $7.9 million from the changes in fair value of derivative warrant liabilities and noapproximately $461,000 in interest income ~~available~~from investments held in the Trust Account, ~~to pay for our tax obligations, if any.~~

~~Prior to~~partially offset by approximately $345,000 in general and administrative expenses and $60,000 in administrative expenses—related party.

For the ~~completion~~six months ended June 30, 2021, we had net income of ~~the Initial Public Offering, our liquidity needs had been satisfied through the payment~~approximately $8.4 million, which consisted of ~~$25,000 from our Sponsor to cover certain expenses in exchange~~a

non-operating

gain of approximately $9.1 million for the ~~issuance~~change in fair value of ~~the Founder Shares, a loan~~derivative warrant liabilities and approximately $29,000 of approximately $98,000 pursuant to a note agreement issued to our Sponsor (the “Note”). We repaid the Note in full on September 16, 2020. Subsequent to the consummation of the Initial Public Offering and Private Placement, our liquidity needs have been satisfied with the proceedsincome from ~~the consummation of the Private Placement not~~investments held in the Trust ~~Account. In addition,~~Account, which was partially offset by approximately $664,000 in ~~order to finance transaction costs~~general and administrative expenses and approximately $60,000 in connection with a Business Combination, our Sponsor may, but is not obligated to, provide us Working Capital Loans. As of September 30, 2020, there were no amounts outstanding under any Working Capital Loan.

Based on the foregoing, management believes that we will have sufficient working capital and borrowing capacity from our Sponsor or an affiliate of our Sponsor, or our officers and directors to meet our needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, we will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

administrative expenses—related party.

~~We continue to evaluate the impact of the~~ ~~COVID-19~~ pandemic and has concluded that the specific impact is not readily determinable as of the date of the balance sheet. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Contractual Obligations

We do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or long-term ~~liabilities, other than~~liabilities.

We entered into an administrative services agreement pursuant to which we have agreed to pay ~~Administrative Services Fees~~our Sponsor a total of $10,000 per month for office space, utilities and administrative support. Upon completion of the Initial Business Combination or our liquidation, the agreement will terminate.

The underwriters of the Initial Public Offering were entitled to ~~our Sponsor.~~

underwriting discounts and commissions of 5.5%, of which 2.0% (approximately $6.5 million) was paid at the closing of the Initial Public Offering and closing of sale of the Over-Allotment Units and 3.5% (approximately $11.3 million) was deferred. The deferred underwriting discounts and commissions will become payable to the underwriters upon the consummation of the Initial Business Combination and will be paid from the amounts held in the Trust Account. The underwriters are not entitled to any interest accrued on the deferred underwriting discounts and commissions.

Critical Accounting Policies

~~This management’s discussion and analysis~~

The preparation of ~~our financial condition and results of operations is based on our~~ financial statements ~~which have been prepared~~ in accordance with accounting principles generally accepted in the United States of ~~America. The preparation of our financial statements~~America requires usmanagement to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and ~~expenses~~expenses. A summary of our significant accounting policies is included in Note 2 to our condensed financial statements in Part I, Item 1 of this Quarterly Report. Certain of our accounting policies are

considered critical, as these policies are the most important to the depiction of our condensed financial statements and require significant, difficult or complex judgments, often employing the ~~disclosure~~use of ~~contingent assets~~estimates about the effects of matters that are inherently uncertain. Such policies are summarized in the Management’s Discussion and ~~liabilities~~Analysis of Financial Condition and Results of Operations section in our ~~financial statements. On an ongoing basis, we evaluate~~2021 Annual Report on Form

10-K

filed with the SEC on March 21, 2022. There have been no significant changes in the application of our estimates and judgments, including those related to fair value of financial instruments and accrued expenses. We base our estimates on historical experience, known trends and events and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The Company has identified the following as its critical accounting ~~policies:~~

~~Class A Ordinary Shares Subject to Possible Redemption~~

Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either withinpolicies during the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. Our Class A ordinary shares feature certain redemption rights that are considered to be outside of our control and subjectsix months ended June 30, 2022.

Recent Accounting Pronouncements

See Note 2 to the occurrence of uncertain future events. Accordingly, at September 30, 2020, 28,596,845 Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.

~~Net Income Per Ordinary Share~~

Net income per share is computed by dividing net income by the weighted-average number of ordinary shares outstanding during the periods. We have not considered the effect of the warrants sold in the Initial Public Offering and the Private Placement to purchase an aggregate of 15,400,000 of the Company’s Class A ordinary shares in the calculation of diluted income per share, since their inclusion would be anti-dilutive under the treasury stock method.

~~Our~~ unaudited condensed ~~statement~~financial statements included in Part I, Item 1 of ~~operations includes~~this Quarterly Report for a ~~presentation~~discussion of ~~income per share for ordinary shares subject to redemption in a manner similar to the~~ ~~two-class~~ method of income per share. Net loss per ordinary share, basic and diluted for Class A ordinary shares are calculated by dividing the loss recognized on investments held in the Trust Account by the weighted average number of Class A ordinary shares outstanding for the period. Net loss per ordinary share, basic and diluted for Class B ordinary shares is calculated by dividing the net loss, less loss attributable to Class A ordinary shares by the weighted average number of Class B ordinary shares outstanding for the period.

~~Recent Accounting Pronouncements~~

~~Our management does not believe that any recently issued, but not yet effective,~~recent accounting ~~standards if currently adopted would have a material effect on the accompanying financial statements.~~

pronouncements.

~~Off-Balance~~ ~~Sheet Arrangements~~

~~As of September 30, 2020, we~~ ~~did not have any off-balance sheet arrangements as defined~~ ~~in Item~~ ~~303(a)(4)(ii) of Regulation S-K.~~

JOBS Act

The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for

non-emerging

growth companies. As a result, the financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of

non-emerging

growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the ~~CEO’s~~Chief Executive Officer’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined by Rule

12b-2

of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are not required to provide the information otherwise required under this item.

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial ~~and accounting~~ officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended ~~September~~June 30, ~~2020,~~2022, as such term is defined in Rules

13a-15(e)

and

15d-15(e)

under the Exchange Act. Based on this evaluation, our ~~chief~~principal executive officer and ~~chief~~principal financial officer ~~have~~has concluded that during the period covered by this report, our disclosure controls and procedures were ~~effective.~~

effective as of June 30, 2022.

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the ~~period from July 21, 2020 (inception) through September~~fiscal quarter ended June 30, ~~2020,~~2022 covered by this Quarterly Report on Form

10-Q

that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

The material weakness discussed below was remediated during the quarter ended June 30, 2022.

Remediation of a Material Weakness in Internal Control over Financial Reporting

We recognize the importance of the control environment as it sets the overall tone for the Company and is the foundation for all other components of internal control. Consequently, we designed and implemented remediation measures to address the material weakness previously identified in fiscal year 2021 and enhance our internal control over financial reporting. In light of the material weakness, we enhanced our processes to identify and appropriately apply applicable accounting requirements to better evaluate and understand the nuances of the complex accounting standards that apply to our condensed financial statements, including providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications. The foregoing actions, which we believe remediated the material weakness in internal control over financial reporting, were completed as of the date of June 30, 2022.

PART ~~II –~~ II—OTHER INFORMATION

Item 1.

Legal Proceedings

~~None.~~

None

Item 1A.

Risk Factors.

~~There~~

Our material risk factors are disclosed in “Risk Factors” in Part I, Item 1A of our Annual Report on Form

10-K.

Other than as set forth below, there have been no material changes from the risk factors previously disclosed in ~~the Company’s most recent prospectus for the Initial Public Offering as filed~~such filing. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risks could arise that may also affect our business or ability to consummate an initial business combination. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.

The current economic downturn may lead to increased difficulty in completing our initial business combination.

Our ability to consummate our initial business combination may depend, in part, on worldwide economic conditions. In recent months, we have observed increased economic uncertainty in the United States and abroad. Impacts of such economic weakness include:

falling overall demand for goods and services, leading to reduced profitability;

reduced credit availability;

higher borrowing costs;

reduced liquidity;

volatility in credit, equity and foreign exchange markets; and

bankruptcies.

These developments could lead to inflation, higher interest rates, and uncertainty about business continuity, which may adversely affect the business of our potential target businesses and create difficulties in obtaining debt or equity financing for our initial business combination, as well as leading to an increase in the number of public stockholders exercising redemption rights in connection therewith.

Recent volatility in capital markets and lower market prices for our securities may affect our ability to obtaining financing for our initial business combination through sales of shares of our common stock or issuance of indebtedness.

With uncertainty in the capital markets and other factors, financing for our initial business combination may not be available on terms favorable to us or at all. If we raise additional funds through further issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences, and privileges superior to those of holders of our common stock. Any debt financing secured by us could involve additional restrictive covenants relating to our capital-raising activities and other financial and operational matters, which may limit the operations and growth of the surviving company of our initial business combination. If we are unable to obtain adequate financing or financing on terms satisfactory to us, we could face significant limitations on our ability to complete our initial business combination.

Changes to laws or regulations or in how such laws or regulations are interpreted or applied, or a failure to comply with any laws, regulations, interpretations or applications, may adversely affect our business, including our ability to negotiate and complete our initial business combination.

We are subject to the laws and regulations, and interpretations and applications of such laws and regulations, of national, regional, state and local governments and non-U.S. jurisdictions. In particular, we are required to comply with certain SEC and potentially other legal and regulatory requirements, and our consummation of an initial business combination may be contingent upon our ability to comply with certain laws, regulations, interpretations and applications and any post-business combination company may be subject to additional laws, regulations, interpretations and applications. Compliance with, and monitoring of, the foregoing may be difficult, time consuming and costly. Those laws and regulations and their interpretation and application may also change from time to time, and those changes could have a material adverse effect on ~~September 11, 2020.~~

our business, including our ability to negotiate and complete an initial business combination. A failure to comply with applicable laws or regulations, as interpreted and applied, could have a material adverse effect on our business, including our ability to negotiate and complete an initial business combination.

On March 30, 2022, the SEC issued proposed rules (the “SPAC Rule Proposals”) relating, among other items, to disclosures in SEC filings in connection with business combination transactions involving special purpose acquisition companies (“SPACs”) and private operating companies; the financial statement requirements applicable to transactions involving shell companies; the use of projections in SEC filings in connection with proposed business combination transactions; the potential liability of certain participants in proposed business combination transactions; and the extent to which SPACs could become subject to regulation under the Investment Company Act, including a proposed rule that would provide SPACs a safe harbor from treatment as an investment company if they satisfy certain conditions that limit a SPAC’s duration, asset composition, business purpose and activities. Certain of the procedures that we, a potential Business Combination target, or others may determine to undertake in connection with the SPAC Rule Proposals, as proposed or as adopted, or pursuant to the SEC’s views expressed in the SPAC Rule Proposals, may increase the costs and time of negotiating and completing an initial business combination, and may constrain the circumstances under which we could complete an initial business combination.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities

On September 9, 2020, Prime Impact Acquisition I (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC and BofA Securities, Inc. (the “Underwriters”), pursuant to which the Company agreed to issue and sell 30,000,000 units (the “Units”), with each Unit consisting of one Class A ordinary share, $0.0001 par value per share (the “Class A Ordinary Shares”), and ~~one-third~~ of one redeemable warrant (the “Public Warrants”), each whole Public Warrant entitling the holder thereof to purchase one Class A Ordinary Share at an exercise price of $11.50 per share, subject to adjustment, to the Underwriters in its initial public offering (“IPO”). On September 14, 2020, the Company consummated the IPO. Pursuant to the Underwriting Agreement, the Company also granted the Underwriters a ~~45-day~~ option from the date of the Underwriting Agreement to purchase up to 4,500,000 additional Units to cover over-allotments, if any (the “Over-allotment Option”). On October 2, 2020, the Underwriters partially exercised the Over-allotment Option to purchase as additional 2,408,414 units (the “Option Units”). Each Option Unit consists of one Class A Ordinary Share and ~~one-third~~ of one Public Warrant. On October 6, 2020, the Company completed the sale of the Option Units to Underwriters for net proceeds of approximately $23,602,457 in the aggregate after deducting the underwriter discount (the “Option Unit Proceeds”). As thus, on October 24, 2022 (the 45^th ~~day follow the Underwriting Agreement), 522,897 Class B ordinary shares were forfeited.~~

Simultaneously with the issuance and sale of the Option Units, the Company consummated the private placement with Prime Impact Cayman, LLC (the “Sponsor”) of 321,122 warrants to purchase Class A Ordinary Shares for $1.50 per warrant in a private placement with each whole warrant entitling the holder thereof to purchase one Class A Ordinary Share at $11.50 per share, subject to adjustment (the “Additional Private Placement Warrants”), generating total proceeds of $481,683 (the “Private Placement Proceeds” and, together with the “Option Unit Proceeds”, the “Proceeds”). The Additional Private Placement Warrants have been issued pursuant to that certain Private Placement Warrant Purchase Agreement, dated September 9, 2020, between the Company and the Sponsor and the Additional Private Placement Warrants are governed by that certain Warrant Agreement, dated September 9, 2020, between the Company and Continental Stock Transfer & Trust Company, as warrant agent.

The Proceeds were placed in a U.S.-based trust account at J.P. Morgan Chase Bank, N.A., maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds in the trust account that may be released to the Company to pay its income taxes, if any, the Proceeds held in the trust account will not be released from the trust account (1) to the Company until the completion of its initial business combination, or (2) to the Company’s public shareholders, until the earliest of: (a) the completion of the Company’s initial business combination, and then only in connection with those Class A Ordinary Shares that such shareholders properly elect to redeem, subject to certain limitations, (b) the redemption of any public shares properly tendered in

connection with a (i) shareholder vote to amend the Company’s amended and restated memorandum and articles of association to modify the substance or timing of its obligation to provide holders of its Class A Ordinary Shares the right to have their shares redeemed in connection with its initial business combination within 24 months from the closing of the IPO or (ii) with respect to any other provisions relating to shareholders’ rights of holders of the Company’s Class A Ordinary Shares or ~~pre-initial~~ business combination activity and (c) the redemption of all of the Company’s public shares if the Company has not completed its initial business combination within 24 months from the closing of the IPO, subject to applicable law.

None.

Item 3.

Defaults Upon Senior Securities

None.

Item 4.

Mine Safety Disclosures

Not applicable.

Item 5.

Other Information

None.

Item 6.

~~Exhibits.~~

Exhibits


Exhibit Number		Description

31.1*		Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*		Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*		Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*		Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

~~SIGNATURES~~

Table of Contents

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated: ~~November 13, 2020~~August 11, 2022	~~Prime Impact Acquisition~~ PRIME IMPACT ACQUISITION I

	By:	/s/ Michael Cordano
	Name:	Michael Cordano
	Title:	Co-Chief Executive Officer ~~(Principal Executive Officer)~~

~~Dated: November 13, 2020~~		(Principal Executive Officer)

	By:	/s/ Mark Long
	Name:	Mark Long
	Title:	Co-Chief Executive Officer and Chief Financial Officer
		(Principal Financial and Accounting Officer)


		Page No.
PART I. FINANCIAL INFORMATION

~~Item 1.~~	~~Financial Statements~~		1

Item 1.	~~Unaudited Condensed Balance Sheet as of September 30, 2020~~Financial Statements		1

	~~Unaudited Condensed Statement of Operations for the period from July 21, 2020 (inception) through September 30, 2020~~		2

	Condensed Balance Sheets as of June 30, 2022 (unaudited) and December 31, 2021		2
	Unaudited Condensed ~~Statement~~Statements of ~~Changes in Shareholders’ Equity~~Operations for the ~~period from July 21, 2020 (inception) through September~~Three and Six Months Ended June 30, ~~2020~~2022 and 2021		3

	Unaudited Condensed ~~Statement~~Statements of ~~Cash Flows~~Changes in Shareholders’ Deficit for the ~~period from July 21, 2020 (inception) through September~~Three and Six Months Ended June 30, ~~2020~~2022 and 2021		4

	~~Notes to~~ Unaudited Condensed ~~Financial~~ Statements of Cash Flows for the Six Months Ended June 30, 2022 and 2021		5

~~Item 2.~~	Notes to Unaudited Condensed Financial Statements		6
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		17

~~Item 3.~~	~~Quantitative and Qualitative Disclosures About Market Risk~~		20

Item 4. 3.	~~Controls~~Quantitative and ~~Procedures~~Qualitative Disclosures About Market Risk		2023

~~PART II. OTHER INFORMATION~~ Item 4.

~~Item 1.~~	~~Legal Proceedings~~Controls and Procedures		2123

~~Item 1A.~~	~~Risk Factors~~PART II. OTHER INFORMATION		21

Item 2. 1.	Legal Proceedings		24
Item 1A.	Risk Factors		24
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities		2124

Item 3.	Defaults Upon Senior Securities		2224

Item 4.	Mine Safety Disclosures		2224

Item 5.	Other Information		2224

Item 6.	Exhibits		2225

SIGNATURES			26


Assets
Current assets:
Cash	$	2,563,468
Prepaid expenses		410,350

Total current assets		2,973,818
Investments held in Trust Account		299,998,798

Total Assets	$	302,972,616

Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable	$	526,857
Accrued expenses		77,300
Advance - related party		900,000

Total current liabilities		1,504,157
Deferred underwriting commissions		10,500,000

Total liabilities		12,004,157

Commitments and Contingencies
Class A ordinary shares; 28,596,845 shares subject to possible redemption at $10.00 per share		285,968,450

Shareholders’ Equity:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding		—
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 1,403,155 shares issued and outstanding (excluding 28,596,845 shares subject to possible redemption)		140
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,625,000 shares issued and outstanding (1)		863
Additional paid-in capital		5,060,460
Accumulated deficit		(61,454	)

Total shareholders’ equity		5,000,009

Total Liabilities and Shareholders’ Equity	$	302,972,616


	June 30, 2022			December 31, 2021
	(unaudited)
Assets
Current assets:
Cash	$	472,528		$	665,940
Prepaid expenses		36,875			110,626

Total current assets		509,403			776,566
Investments held in Trust Account		324,671,738			324,211,180

Total Assets	$	325,181,141		$	324,987,746

Liabilities, Class A Ordinary Shares Subject to Redemption and Shareholders’ Deficit
Current liabilities:
Accounts payable	$	412,862		$	327,477
Accrued expenses		212,001			159,535

Total current liabilities		624,863			487,012
Derivative warrant liabilities		991,435			8,922,920
Deferred underwriting commissions		11,342,945			11,342,945

Total Liabilities		12,959,243			20,752,877
Commitments and Contingencies		0			0
Class A ordinary shares subject to possible redemption, $0.0001 par value; 32,408,414 shares issued and outstanding at $10.02 and $10.00 per share redemption value as of June 30, 2022 and December 31, 2021, respectively		324,571,738			324,084,140
Shareholders’ Deficit:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; 0 shares issued or outstanding		0—			0—
Class A ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 0 non-redeemable shares issued or outstanding		—			—
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,102,103 shares issued and outstanding as of June 30, 2022 and December 31, 2021		810			810
Additional paid-in capital		—			—
Accumulated deficit		(12,350,650	)		(19,850,081	)

Total Shareholders’ Deficit		(12,349,840	)		(19,849,271	)

Total Liabilities, Class A Ordinary Shares Subject to Redemption and Shareholders’ Deficit	$	325,181,141		$	324,987,746


	For the Period From July 21, 2020 (Inception) through September 30, 2020
General and administrative expenses	$	50,264
Administrative expenses - related party		10,000

Loss from operations		(60,264	)
Interest income		12
Net loss from investments held in Trust Account		(1,202	)

Net loss		(61,454	)

Weighted average Class A ordinary shares outstanding, basic and diluted		30,000,000

Basic and diluted net loss per ordinary share	$	0.00

Weighted average Class B ordinary shares outstanding, basic and diluted (1)		8,102,103

Basic and diluted net loss per ordinary share	$	(0.01	)


	For the Three Months Ended June 30,						For the Six Months Ended June 30,
	2022			2021			2022			2021
General and administrative expenses	$	81,618		$	172,449		$	345,046		$	664,035
Administrative expenses - related party		30,000			30,000			60,000			60,000
Loss from operations		(111,618	)		(202,449	)		(405,046	)		(724,035	)
Other income (expense)
Change in fair value of derivative warrant liabilities		2,974,307			(2,917,095	)		7,931,485			9,100,948
Interest income		16			30			33			77
Income from investments held in Trust Account		429,733			11,765			460,557			29,498

Net income (loss)	$	3,292,438		$	(3,107,749	)	$	7,987,029		$	8,406,488
Weighted average Class A ordinary shares outstanding, basic and diluted		32,408,414			32,408,414			32,408,414			32,408,414

Basic and diluted net income (loss) per Class A ordinary share	$	0.08		$	(0.08	)	$	0.20		$	0.21

Weighted average Class B ordinary shares outstanding, basic and diluted		8,102,103			8,102,103			8,102,103			8,102,103

Basic and diluted net income (loss) per Class B ordinary share	$	0.08		$	(0.08	)	$	0.20		$	0.21


	Ordinary Shares										Additional Paid-in Capital			Accumulated Deficit			Total Shareholders’ Equity
	Class A						Class B
	Shares			Amount			Shares		Amount
Balance - July 21, 2020 (inception)		—		$	—			—	$	—	$	—		$	—		$	—
Issuance of Class B ordinary shares to Sponsor (1)		—			—			8,625,000		863		24,137			—			25,000
Sale of units in initial public offering, gross		30,000,000			3,000			—		—		299,997,000			—			300,000,000
Offering costs		—			—			—		—		(17,095,087	)		—			(17,095,087	)
Sale of private placement warrants to Sponsor		—			—			—		—		8,100,000			—			8,100,000
Shares subject to possible redemption		(28,596,845	)		(2,860	)		—		—		(285,965,590	)		—			(285,968,450	)
Net loss		—			—			—		—		—			(61,454	)		(61,454	)

Balance - September 30, 2020 (unaudited)		1,403,155		$	140			8,625,000	$	863	$	5,060,460		$	(61,454	)	$	5,000,009


	Ordinary Shares								Additional					Total
	Class A				Class B				Paid-in		Accumulated			Shareholders’
	Shares		Amount		Shares		Amount		Capital		Deficit			Deficit
Balance - December 31, 2021		—	$	—		8,102,103	$	810	$	—	$	(19,850,081	)	$	(19,849,271	)
Net income		—		—		—		—		—		4,694,591			4,694,591
Increase in redemption value of Class A ordinary shares subject to redemption		—		—		—		—		—		(57,864	)		(57,864	)

Balance - March 31, 2022 (unaudited)		—	$	—		8,102,103	$	810	$	—	$	(15,213,354	)	$	(15,212,544	)
Net income		—		—		—		—		—		3,292,438			3,292,438
Increase in redemption value of Class A ordinary shares subject to redemption		—		—		—		—		—		(429,734	)		(429,734	)

Balance - June 30, 2022 (unaudited)		—	$	—		8,102,103	$	810	$	—	$	(12,350,650	)	$	(12,349,840	)


Cash Flows from Operating Activities:
Net loss	$	(61,454	)
Adjustments to reconcile net loss to net cash used in operating activities:
General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares		25,000
General and administrative expenses paid by Sponsor under note payable		100
Net loss from investments held in Trust Account		1,202
Changes in operating assets and liabilities:
Prepaid expenses		(410,350	)
Accounts payable		416,324
Accrued expenses		2,300

Net cash used in operating activities		(26,878	)

Cash Flows from Investing Activities:
Cash deposited in Trust Account		(300,000,000	)

Net cash used in investing activities		(300,000,000	)

Cash Flows from Financing Activities:
Advance - related party		900,000
Repayment of note payable to Sponsor		(98,301	)
Proceeds received from initial public offering, gross		300,000,000
Proceeds received from private placement		8,100,000
Offering costs paid		(6,311,353	)

Net cash provided by financing activities		302,590,346

Net increase in cash		2,563,468

Cash - beginning of the period		—

Cash - ending of the period	$	2,563,468

Supplemental disclosure of noncash investing and financing activities:
Offering costs included in accounts payable	$	110,533
Offering costs included in accrued expenses	$	75,000
Offering costs included in note payable	$	98,201
Deferred underwriting commissions	$	10,500,000
Initial value of Class A ordinary shares subject to possible redemption	$	286,032,440
Change in initial value of Class A ordinary shares subject to possible redemption	$	63,990


	Quoted Prices in Active Markets		Significant Other Observable Inputs		Significant Other Unobservable Inputs
Description	(Level 1)		(Level 2)		(Level 3)
Assets held in Trust Account:
U.S. Treasury Securities	$	299,992,977	$	—	$	—
Cash equivalents – money market funds		5,082		—		—

	$	299,998,798	$	—	$	—